ReviewJournal of feline medicine and surgery2026
Cutaneous paraneoplastic syndromes in cats: a comparative clinical review.
Review in Journal of feline medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
practical relevanceCutaneous paraneoplastic syndromes (CPSs) in cats represent a diverse group of rare dermatological manifestations that occur as indirect consequences of underlying neoplasia. These syndromes are thought to arise due to tumour-associated systemic effects, including dysregulation of immune responses, metabolic disturbances and aberrant production of cytokines or growth factors. Recognising CPSs is clinically relevant, as they may serve as early indicators of occult neoplasia, guiding timely diagnosis and intervention. CLINICAL CHALLENGES: Diagnosing CPSs requires a high index of suspicion, particularly in older cats with atypical dermatological presentations. Skin biopsies are needed for distinguishing CPSs from primary dermatopathies, and imaging investigations aid in tumour localisation. The treatment for CPSs involves addressing the underlying malignancy. In cases where surgical resection or chemotherapy successfully reduce tumour burden, partial or complete resolution of cutaneous signs has been documented. However, the prognosis remains guarded, particularly for aggressive neoplasms such as pancreatic and biliary carcinomas.
aimsThis review aims to consolidate the current knowledge on feline CPSs, focusing on their clinical presentation, pathophysiology, diagnostic approach and therapeutic options. It also aims to summarise current knowledge and identify gaps that can inform future research, with the ultimate goal of advancing understanding and increasing awareness among veterinarians of these complex conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.